This study, for the first time, revealed that TUG1 was upregulated in CRC recurrence tissues and 5-FU resistant cell lines, with the findings of the study highlighting the potential value of TUG1 as a predictive biomarker [227]. The gene discussed is TUG1; the disease is colorectal carcinoma.